As a core subsidiary of the pharmaceutical sector of Hualu Holding Group Co., Ltd., the company was founded in 1943 at the Jiaodong anti-Japanese base. It is the first chemically synthesized pharmaceutical company in New China, an important production and export base for antipyretic analgesics in the world, and an important domestic manufacturer of cardiovascular, cerebrovascular, anti-infective, central nervous system, etc. The Company and its subsidiaries are mainly engaged in the development, manufacture and sale of chemical raw materials, formulations, pharmaceutical intermediates and other products. The company's main products are “Xinhua brand” antipyretic and analgesic drugs, cardiovascular, cerebrovascular, anti-infective and central nervous system drugs. The honors received by the company include advanced grass-roots party organizations of provincial management enterprises, enterprises targeted for cultivating century-old brands, and the list of the top 1,000 innovation capabilities of Chinese enterprises.
No Data
No Data
No Data
No Data
No Data
No Data
No Data
No Data
No Data
No Data
No Data
No Data
No Data
No Data
No Data
No Data
No Data
No Data
No Data
No Data
No Data
No Data